Loading...
CGS logo
CGS
Cogstate

Medidata Partnership And AI Launch Will Expand Global Reach

Published
11 Feb 25
Updated
22 Aug 25
AnalystConsensusTarget's Fair Value
AU$2.19
9.1% overvalued intrinsic discount
04 Sep
AU$2.39
Loading
1Y
165.6%
7D
2.6%

Author's Valuation

AU$2.199.1% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Narrative
Updates9

Shared on22 Aug 25
Fair value Increased 18%

Upward revisions to Cogstate's revenue growth forecasts and a higher future P/E multiple have driven the consensus analyst price target up from A$1.85 to A$2.19. What's in the News Hosted an Analyst/Investor Day event.

Read more

Shared on01 May 25
Fair value Increased 26%

Read more

Shared on23 Apr 25
Fair value Increased 1.38%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on17 Apr 25
Fair value Increased 2.11%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on09 Apr 25
Fair value Decreased 8.97%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on02 Apr 25
Fair value Increased 4.00%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on26 Mar 25
Fair value Decreased 0.66%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on19 Mar 25
Fair value Increased 1.34%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on13 Mar 25
Fair value Decreased 19%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more